| Database ID | Agent | Target | Cancer Type | Detail |
| DB00151 | everolimus | Serine/threonineprotein kinase mTOR | liver cancer | view |
| DB00152 | temsirolimus | Serine/threonineprotein kinase mTOR | liver cancer | view |
| DB00153 | sirolimus/rapamycin | Serine/threonineprotein kinase mTOR | liver cancer | view |
| DB00154 | ganetespib | VEGFR, cMET, human epidermal growth factor receptor 2, IGFIR, EGFR, and other Hsp90 client proteins | liver cancer | view |
| DB00155 | tremelimumab | cytotoxic Tlymphocyteassociated antigen 4 (CTLA4) | liver cancer | view |
| DB00156 | mapatumumab | Tumor necrosis factor receptor superfamily member 10A | non small cell lung cancer | view |
| DB00157 | mapatumumab | Tumor necrosis factor receptor superfamily member 10A | advanced solid tumors | view |
| DB00158 | veliparib | Poly [ADPribose] polymerase1 | advanced solid tumors | view |
| DB00159 | veliparib | Poly [ADPribose] polymerase1 | advanced solid tumors | view |
| DB00160 | veliparib | Poly [ADPribose] polymerase1 | advanced solid tumors | view |
| DB00161 | navitoclax | Bcl2like protein 2
Antiapoptotic protein BCLXL
Apoptosis regulator Bcl2 | advanced solid tumors | view |
| DB00162 | navitoclax | Bcl2like protein 2
Antiapoptotic protein BCLXL
Apoptosis regulator Bcl2 | smallcell lung cancer | view |
| DB00163 | MDX1106 | PD1 | advanced solid tumors | view |
| DB00164 | BMS936558 | PD1 | advanced solid tumors | view |
| DB00165 | BMS936559 | Programmed cell death ligand 1 (PDL1) | advanced solid tumors | view |